| 书目名称 | Immunology of Malignant Diseases | | 编辑 | V. S. Byers,R. W. Baldwin | | 视频video | http://file.papertrans.cn/463/462239/462239.mp4 | | 丛书名称 | Immunology and Medicine | | 图书封面 |  | | 描述 | Over the past 5 years, clinical immunology, as a whole, has advanced more rapidly than over the past 20 years. Many of these advances have been que to monoclonal antibody technology with its ability to identify antigens on tumour cells with a precision never before available. Monoclonal antibodies have the ability to identify subsets of human T-Iymphocytes and aid in diagnosis of both immunodeficiency disorders such as AIDS, or autoimmune diseases, and they can be adapted as drug targeting agents. Additionally, however, major advances have been made in identifying immunomodulating agents, and the last year has seen two such agents, IL-2 and OKT3, made available commercially for such intervention. Furthermore, another immuno modulating technique, bone marrow transplantation, ha~ now been established as a curative modality in leukaemia treatment. A central issue in tumour immunology is whether human tumours express antigens which can be termed tumour-specific. This has important implications for both tumour immunity as well as drug targeting. This issue is considered in detail by R. A. Robins in the introductory chapter in which the expression of antigens in human tumours is compare | | 出版日期 | Book 1987 | | 关键词 | blood; diseases; immunobiology; lymphocytes; melanoma; transplantation; tumor | | 版次 | 1 | | doi | https://doi.org/10.1007/978-94-009-3219-7 | | isbn_softcover | 978-94-010-7945-7 | | isbn_ebook | 978-94-009-3219-7 | | copyright | MTP Press Limited 1987 |
The information of publication is updating
|
|
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-24 13:55
发表于 2025-3-21 16:24:38
